Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Di-Genic Inheritance in Genodermatoses: Insights from Two Consanguineous Cases in a Reference Lebanese Center within the Middle East and North Africa (MENA) Region. | Dermatol Pract Concept | 2025 | 39853250 | PubTator, text mining | PubMed |
| Application of Gene Editing in Triple-Negative Breast Cancer Research. | Cell Biochem Funct | 2025 | 39844394 | PubTator, text mining | PubMed |
| FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction. | Cell Commun Signal | 2025 | 39773485 | PubTator, text mining | PubMed |
| FoxC1 activates Notch3 signaling to promote the inflammatory phenotype of keloid fibroblasts and aggravates keloid. | Exp Cell Res | 2025 | 39753198 | PubTator, text mining | PubMed |
| Potential Involvements of Anterior Segment Dysgenesis-Associated Genes in Primary Congenital Glaucoma. | Semin Ophthalmol | 2025 | 39652009 | PubTator, text mining | PubMed |
| Mitochondrial-Derived Signaling Mediates Differentiation of Parietal Epithelial Cells into Podocytes. | Antioxid Redox Signal | 2025 | 39212658 | PubTator, text mining | PubMed |
| BPTF promotes glioma development through USP34-mediated de-ubiquitination of FOXC1. | Histol Histopathol | 2025 | 38686761 | PubTator, text mining | PubMed |
| LncRNA RMRP promotes chondrocyte injury by regulating the FOXC1/RBP4 axis. | Cent Eur J Immunol | 2024 | 39944260 | PubTator, text mining | PubMed |
| Comparative study of the three-dimensional genomes of granulosa cells in germinal vesicle and metaphase II follicles. | Front Genet | 2024 | 39634272 | PubTator, text mining | PubMed |
| LINC01614 Promotes Oral Squamous Cell Carcinoma by Regulating FOXC1. | Genes (Basel) | 2024 | 39596660 | PubTator, text mining | PubMed |
| Deletion of exon 4 of the PITX2 in a child with Axenfeld-Rieger syndrome. | Ophthalmic Genet | 2024 | 39587444 | PubTator, text mining | PubMed |
| FOXC1 and retinopathy: targeting molecular mechanisms in retinal blood vessel growth. | Expert Opin Ther Targets | 2024 | 39560136 | PubTator, text mining | PubMed |
| A Novel Mutation of FOXC1 (P136L) in an Axenfeld-Rieger Syndrome Patient With a Systematized Delusion of Jealousy: A Case Report and Literature Review. | Mol Genet Genomic Med | 2024 | 39520097 | PubTator, text mining | PubMed |
| Integrative Analysis of ATAC-Seq and RNA-Seq through Machine Learning Identifies 10 Signature Genes for Breast Cancer Intrinsic Subtypes. | Biology (Basel) | 2024 | 39452108 | PubTator, text mining | PubMed |
| A De Novo Noncoding RARB Variant Associated with Complex Microphthalmia Alters a Putative Regulatory Element. | Hum Mutat | 2024 | 39450403 | PubTator, text mining | PubMed |
| Genetic analysis using next-generation sequencing and multiplex ligation probe amplification in Chinese aniridia patients. | Orphanet J Rare Dis | 2024 | 39449022 | PubTator, text mining | PubMed |
| USP10 promotes pancreatic ductal adenocarcinoma progression by attenuating FOXC1 protein degradation to activate the WNT signaling pathway. | Int J Biol Sci | 2024 | 39430239 | PubTator, text mining | PubMed |
| Diagnostic Challenges of Axenfeld-Rieger Syndrome and a Novel FOXC1 Gene Mutation in a Polish Family. | J Clin Med | 2024 | 39407821 | PubTator, text mining | PubMed |
| Exploring the Potential of Enhanced Prognostic Performance of NCCN-IPI in Diffuse Large B-Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression. | Cancer Med | 2024 | 39404228 | PubTator, text mining | PubMed |
| Forkhead box C1 promotes the pathology of osteoarthritis in subchondral bone osteoblasts via the Piezo1/YAP axis. | Cell Signal | 2024 | 39396563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=10